Evaluating Adjuvant Atezolizumab or Atezolizumab and Hyaluronidase-TQJS to Prevent Recurrence in Stage I Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase III Trial (AASI-NSCLC)
NCT07388524 · NOT YET RECRUITING · Phase 3
There are 5 Phase 3 clinical trials for Lung Non Small Cell Carcinoma tracked on ReadTheTrial. This represents 42% of all 12 Lung Non Small Cell Carcinoma trials.
Phase 3 trials for Lung Non Small Cell Carcinoma represent a critical late-stage segment of the research pipeline. Currently, 2 of these trials are actively recruiting participants.
Phase 3 trials for Lung Non Small Cell Carcinoma are clinical studies at this specific development stage. There are currently 5 such trials tracked on ReadTheTrial.
Review the individual trial pages for eligibility criteria and recruiting status. Currently 2 Phase 3 Lung Non Small Cell Carcinoma trials are recruiting. Discuss participation with your doctor.
Multiple organizations sponsor these trials.